Jjml. Hoffmann et al., Haemostatic effects of low osmolar non-ionic and ionic contrast media: a double-blind comparative study, BR J RADIOL, 73(867), 2000, pp. 248-255
Citations number
29
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Medical Research Diagnosis & Treatment
In this prospective, double-blind, randomized study the effects of a non-io
nic contrast medium (Iopromide) on the haemostatic system were compared wit
h those of a low osmolar ionic medium (Ioxaglate). The aim was to investiga
te in vivo whether a non-ionic contrast agent is less anticoagulant or more
pro-thrombotic than an ionic medium. A large number of haemostatic paramet
ers, including activation markers, were measured. Either Iopromide (n=16; m
edian volume 102 ml, 95% confidence interval 90-108 ml) or Ioxaglate (n=15;
median 105 ml; 95% confidence interval 95-114 ml) was given to 31 patients
scheduled for abdominal and femoral arteriography. Blood for laboratory in
vestigations was collected before, and 5 and 30 min after, administering th
e contrast medium. Indications for activation of coagulation and platelets
were already found in nearly 50% of the patients before any contrast medium
was given. Both Iopromide and Ioxaglate caused further increases in thromb
in-antithrombin complex, prothrombin fragments 1+2 and beta-thromboglobulin
. The degree of activation was similar for both agents. Anticoagulant effec
ts were not observed. The haemorheological effects were compatible with hae
modilution by 5-8%, again without differences between the contrast agents.
Contrary to the findings from in vitro studies, we found no significant dif
ferences between the effects of the non-ionic Iopromide and the ionic Ioxag
late on coagulation and platelets. Both agents activated these systems to a
limited, but identical, degree. Our results support the notion that the ca
theterization procedure pet sc may represent a source of haemostatic activa
tion and that the ionic contrast agent studied has insufficient anticoagula
nt effect to prevent clotting activation being induced by the contrast medi
um.